Found 6 matching trials
A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. PHASE1 Trial Objectives:
The objective is to investigate the efficacy and safety ...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer PHASE1 This study sets out to determine the maximum tolerated dose (MTD) of afatin...
Show More Location
Ludwig-Maximilians - University of Munich
Learn More & Join Trial
Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) PHASE2 The primary objectives of the trial is to examine the toxicities and effica...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib N/A Non-interventional, multi-country, multi-centre cohort study based on exist...
Show More Location
Royal Marsden Hospital
Learn More & Join Trial
Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity PHASE2 To assess if targeting activating EGFR and HER2 mutations in Non-Small Cell...
Show More Location
Aberdeen Royal Infirmary (NHS Grampian)
Learn More & Join Trial
To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation PHASE4 This is an open-label, sing-arm, single site, phase IV clinical study. The ...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial